An <i>In Silico</i> Study of the Interactions of Alkaloids from <i>Cryptolepis sanguinolenta</i> with <i>Plasmodium falciparum</i> Dihydrofolate Reductase and Dihydroorotate Dehydrogenase

<div>Cartoon representation of the various domains of the <i>Plasmodium falciparum</i> DHFR-TS bifunctional enzyme and the <i>Plasmodium falciparum</i> DHODH proteins. Both enzymes are validated targets for the development of malaria chemotherapy.</div>

Journal of Chemistry

fig1

Figure 1

Figure 1: An <i>In Silico</i> Study of the Interactions of Alkaloids from <i>Cryptolepis sanguinolenta</i> with <i>Plasmodium falciparum</i> Dihydrofolate Reductase and Dihydroorotate Dehydrogenase 

Figure 1 | An In Silico Study of the Interactions of Alkaloids from Cryptolepis sanguinolenta with Plasmodium falciparum Dihydrofolate Reductase and Dihydroorotate Dehydrogenase 